| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
STATE COLLEGE, Pa.—Nanotechnology and materials specialist NanoHorizons announced early in February that it had been issued a patent for its deposited thin-film system, QuickMass, for high-throughput small-molecule MS. According to Dr. Dan Hayes, NanoHorizons manager of operations, the new system brings the benefits of MALDI-MS to a field that has traditionally been dominated by liquid chromatography-electrospray ionization (LC-ESI) MS.
 
Small molecules are typically analyzed using LC-ESI MS because they fall below the molecular weight cut-off generally associated with MALDI analysis and their signals become confused with those related to matrix compounds. According to Nano-Horizons, however, QuickMass-enabled targets allow researchers to generate small-molecule spectra using matrix-less or thin-layer matrix techniques.
 
"The new system facilitates low-molecular weight analysis in the range of 0-2000 amu, which covers all small molecules and some peptides," Dr. Hayes says. "And if researchers spot a sample twice, using QuickMass and then traditional matrices, they can do both low- and high-molecular weight analyses on the same sample."
 
A patented nanoscale non-porous germanium layer is used to desorb the laser energy of the MALDI instrument, removing the need for matrix and allowing the user to acquire clear spectra below 1000 Da. According to Dr. Hayes, the QuickMass method translates into significant time and cost reductions for pharmaceutical development, ADME testing, and natural product research.
 
"It's really a matter of speed," he adds. "It can take minutes to analyze individual samples using LC, while MALDI spectra can be generated in seconds."
 
That being said, Dr. Hayes cautions, the method is really only appropriate for people performing high-throughput sampling, al-though it offers performance characteristics comparable to ESI.
 
QuickMass is already being used by Kratos Analytical, a subsidiary of Shimadzu Biotech, but Dr. Hayes explains that the platform can be used on any mass spectrometer and NanoHorizons designs sample plates to suit most. And because the method involves low-temperature deposition, on practically any substrate, which offers significant savings to users.
 
This also means that researchers can discard the target after a single use, a feature that is becoming more attractive as companies look to limit or eliminate problems of cross-contamination. Also, because Quick-Mass relies on germanium rather than labile, organic matrices, users can store sample plates indefinitely at room temperature, without degradation, for archival purposes and future retesting.
 
"Single-use targets are rapidly gaining popularity with high-volume users of MALDI instruments," says Dr. Hayes.
 
QuickMass-enhanced MS will help researchers extend the useful range of their MALDI instruments while avoiding complex handling, storage, cleaning, and anti-contamination procedures.

About the Author

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue